Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover comparison of Budesonide/formoterol Easyhaler vs Symbicort Turbuhaler in asthma
2014-002705-38Phase 3Completed
- Sponsor
- Orion Corporation
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide + formoterol in asthma (2 arms), sponsored by Orion Corporation. Primary endpoint: Average 12-hour FEV1. Started Oct 2014; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2014-002705-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002705-38.